Buy me a coffee · $1
×

Support us with a small donation 💝

Every coffee keeps the site running. Thank you!

Clinical Trial Decentralization Drives Adoption of Remote Patient Monitoring

 ·  1 min read

Pharmaceutical research organizations are increasingly structuring Phase II and Phase III clinical trials around decentralized, sensor-driven monitoring protocols.

Data Fidelity
Continuous biometric data collection offers researchers higher longitudinal fidelity than periodic in-clinic evaluations, improving early detection of adverse events and efficacy signals.

Operational Efficiency
Decentralized models reduce trial drop-out rates by over 30%, cutting overall drug development timelines and associated capital expenditures significantly.